ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GTX Genetix Grp

84.00
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Genetix Grp LSE:GTX London Ordinary Share GB0001276863
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 84.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Rule 2.10 Announcement

18/12/2009 12:00pm

UK Regulatory



 

TIDMGTX 
 
RNS Number : 3837E 
Genetix Group PLC 
18 December 2009 
 
 
 
 
 
New Milton, 18 December 2009 
Genetix Group plc - Rule 2.10 Announcement 
In accordance with Rule 2.10 of the City Code on Takeovers and Mergers, Genetix 
Group plc confirms that it has 72,584,509 ordinary shares of 50 pence each in 
issue and admitted to trading on the AIM market of the London Stock Exchange plc 
as at 18 December 2009. The International Securities Identification Number 
(ISIN) for the ordinary shares is GB0001276863. 
Genetix Group plc 
Charles de Rohan, Chief Executive 
Andrew Kellett, Finance Director 
Tel: 01425 624600 
 
 
Piper Jaffray Ltd. 
Neil Mackison 
Tel 020 3142 8700 
 
 
Dealings Disclosure Requirements 
Under the provisions of Rule 8.3 of the City Code on Takeovers and Mergers (the 
"Code"), if any person is, or becomes, "interested" (directly or indirectly) in 
1% or more of any class of "relevant securities" of Genetix Group plc 
("Genetix") or Danaher Corporation ("Danaher"), all "dealings" in any " relevant 
securities" of Genetix or Danaher (including by means of an option in respect 
of, or a derivative referenced to, any such "relevant securities") must be 
publicly disclosed by no later than 3.30 pm (London time) on the London business 
day following the date of the relevant transaction. This requirement will 
continue until the date on which the offer becomes, or is declared, 
unconditional as to acceptances, lapses or is otherwise withdrawn or on which 
the "offer period" otherwise ends. If two or more persons act together pursuant 
to an agreement or understanding, whether formal or informal, to acquire an 
"interest" in "relevant securities" of Genetix or Danaher, they will be deemed 
to be a single person for the purpose of Rule 8.3. 
Under the provisions of Rule 8.1 of the Code, all "dealings" in "relevant 
securities" of Genetix or Danaher by Genetix or Danaher, or by any of their 
respective "associates", must be disclosed by no later than 12.00 noon (London 
time) on the London business day following the date of the relevant transaction. 
 
A disclosure table, giving details of the companies in whose "relevant 
securities" "dealings" should be disclosed, and the number of such securities in 
issue, can be found on the Takeover Panel's website at 
www.thetakeoverpanel.org.uk. 
"Interests in securities" arise, in summary, when a person has long economic 
exposure, whether conditional or absolute, to changes in the price of 
securities. In particular, a person will be treated as having an "interest" by 
virtue of the ownership or control of securities, or by virtue of any option in 
respect of, or derivative referenced to, securities. Terms in quotation marks 
are defined in the Code, which can also be found on the Panel's website. If you 
are in any doubt as to whether or not you are required to disclose a "dealing" 
under Rule 8, you should consult the Panel. 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 RTTEAFAPFSPNFFE 
 

1 Year Genetix Grp Chart

1 Year Genetix Grp Chart

1 Month Genetix Grp Chart

1 Month Genetix Grp Chart

Your Recent History

Delayed Upgrade Clock